​

Funding Round

Series B - Aura Biosciences

Series B - Aura Biosciences

Investment Firm

Overview

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

Announced Date

Mar 05, 2015

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Advent Life Sciences

Advent Life Sciences

Advent Life Sciences is a early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

8

Investor Name
Participant InvestorLysosomal Therapeutics
Participant InvestorHenri Termeer
Participant InvestorYsios Capital
Participant InvestorPappas Ventures
Participant InvestorAdvent Life Sciences

Round Details and Background

Aura Biosciences raised $21000000 on 2015-03-05 in Series B

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

Company Funding History

15

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 08, 2014
Debt Financing - Aura Biosciences
-1.3M
Dec 26, 2012
Venture Round - Aura Biosciences
-3.2M
Sep 01, 2010
Series A - Aura Biosciences
-1.4M
Aug 26, 2011
Series A - Aura Biosciences
-3.0M

Recent Activity

There is no recent news or activity for this profile.